Eli Lilly and Company Press Releases

LLY 
$70.79
*  
0.14
0.2%
Get LLY Alerts
*Delayed - data as of Mar. 5, 2015 9:45 ET  -  Find a broker to begin trading LLY now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    LLY Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Lilly and IU School of Medicine Partner on Rotation Program for Medical Students
3/4/2015 9:00:00 AM - PR Newswire


Lilly to Participate in Barclays Global Healthcare Conference
3/3/2015 2:30:00 PM - PR Newswire


Elanco Supports East Africa Dairy Development Project with $1.5 Million Matching Challenge
3/3/2015 10:36:00 AM - Business Wire


Denovo Biopharma Licenses Late-Stage Neuroscience Drug From Lilly For Development As A Personalized Medicine
3/3/2015 8:00:00 AM - PR Newswire


Lilly to Present at Cowen Health Care Conference
2/24/2015 2:00:00 PM - PR Newswire


Lilly Announces Update on Regulatory Submission Timing for Basal Insulin Peglispro
2/23/2015 8:30:00 AM - PR Newswire


Lilly Announces Update on Regulatory Submission Timing for Basal Insulin Peglispro
2/23/2015 8:30:00 AM - PR Newswire


Baricitinib Superior to Placebo in Reducing Rheumatoid Arthritis Disease Activity in Second Phase 3 Study
2/23/2015 7:00:00 AM - PR Newswire


Shareholders of Synacor Nominate Three Highly Qualified Directors for Election at Synacor''s 2015 Annual Meeting of Stockholders
2/23/2015 7:00:00 AM - PR Newswire


NASCAR Driver Ryan Reed Takes First Place At Daytona International Speedway
2/21/2015 8:22:00 PM - PR Newswire


Lilly Provides Update on Evacetrapib Phase 3 Trial
2/19/2015 8:00:00 AM - PR Newswire


Groupe Athena, Inc. Issues Update on Atorvastatin Calcium Project
2/19/2015 8:00:00 AM - eTeligis


Students with Type 1 Diabetes Get a Boost from Lilly Diabetes to Attend College
2/11/2015 9:00:00 AM - PR Newswire


Lilly to Present at Leerink Global Healthcare Conference
2/6/2015 11:00:00 AM - PR Newswire


The Lilly Foundation Commits $1 Million to Support AMPATH Oncology Institute in Kenya
2/4/2015 8:00:00 AM - PR Newswire


Lilly Diabetes Donates $92,000 in Camp Scholarships to the American Diabetes Association
2/3/2015 9:05:00 AM - PR Newswire


U.S. FDA approves first-in-class Glyxambi® (empagliflozin/linagliptin) tablets for adults with type 2 diabetes
2/2/2015 8:30:00 AM - PR Newswire


Lilly Reports Fourth-Quarter and Full-Year 2014 Results, Updates 2015 Guidance
1/30/2015 6:25:00 AM - PR Newswire


Scoring Progress Against Cancer: New Tool Measures Cancer Progress to Help Inform Research and Policy Decisions
1/29/2015 8:00:00 AM - PR Newswire


Bristol-Myers Squibb and Lilly Enter Clinical Collaboration Agreement to Evaluate Opdivo (nivolumab) in Combination with Galunisertib in Advanced Solid Tumors
1/13/2015 8:00:00 AM - Business Wire
▲1.97 % Price Change since this news event. The Volume Ratio is 0.51.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly, Merck Enter Collaboration Agreement to Research Immuno-Oncology Combination Regimens in Multiple Types of Cancer
1/13/2015 8:00:00 AM - Business Wire


Lilly Provides Update on Strategy and Announces 2015 Financial Guidance
1/7/2015 7:30:00 AM - PR Newswire
▲2.05 % Price Change since this news event. The Volume Ratio is 3.01.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly to Present at J.P. Morgan Healthcare Conference
1/5/2015 4:09:00 PM - PR Newswire
▲2.05 % Price Change since this news event. The Volume Ratio is 2.04.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly Announces Promotion of Darren J. Carroll to Senior Vice President of Corporate Business Development
1/5/2015 9:00:00 AM - PR Newswire
▲1.29 % Price Change since this news event. The Volume Ratio is 2.54.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly Finalizes Novartis Animal Health Acquisition
1/1/2015 1:00:00 AM - PR Newswire
▲2.61 % Price Change since this news event. The Volume Ratio is 1.7.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day